Samuel Listi in Dallas, Texas

Home Texas Dallas

Samuel Listi has Internal Medicine as his primary medical specialty. Their primary office is: 7930 Northaven Rd in Dallas, Texas. There is an additional office location, for a total of two, for Samuel Listi that can be viewed further down. They attended University Of Texas Southwestern Medical School At Dallas and graduated in 1981 (around 43 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Samuel J Listi Office Phone and Directions

Samuel Listi
7930 Northaven Rd
Dallas, Texas 75230
214-706-8200

Patient Ratings
Please rate your experience with Samuel Listi below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 214-706-8200

Enter a starting address:

Healthcare Info for Samuel Listi

Medical School: University Of Texas Southwestern Medical School At Dallas
Graduation Year: 1981
The Primary Medical Specialty for Samuel Listi is listed as: Internal Medicine
Approximate Years of Experience: 43
PAC (PECOS ID)#: 7810094158
NPI #: 1225033244
NPI Created On: 06/16/2005
NPI Last Updated Listed as: 11/13/2007
Primary Taxonomy Code: 207R00000X
License Number:
F9738
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $50

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 854244871

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Pain Management

Name of Drug #1: ANJESO

Open Associated Drug #1: 71518-001-01